These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17123949)

  • 1. Heparin-induced thrombocytopenia: advances in diagnosis and treatment.
    Cooney MF
    Crit Care Nurse; 2006 Dec; 26(6):30-6; quiz 37. PubMed ID: 17123949
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia: a general review.
    Swanson JM
    J Infus Nurs; 2007; 30(4):232-40. PubMed ID: 17667079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anesthesia provider's perspective of heparin-induced thrombocytopenia.
    Woodyard DN
    AANA J; 2005 Apr; 73(2):115-9. PubMed ID: 15835831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia: what clinicians need to know.
    Chong BH; Isaacs A
    Thromb Haemost; 2009 Feb; 101(2):279-83. PubMed ID: 19190810
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia--a big deal? It should be!
    Jamani N; Ouwendyk M
    CANNT J; 2000; 10(2):30-5, 39-44; quiz 36-8. PubMed ID: 15712466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argatroban, a new treatment option for heparin-induced thrombocytopenia.
    Cleveland KW
    Crit Care Nurse; 2003 Dec; 23(6):61-6. PubMed ID: 14692173
    [No Abstract]   [Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia: principles for early recognition and management.
    Bartholomew JR; Begelman SM; Almahameed A
    Cleve Clin J Med; 2005 Apr; 72 Suppl 1():S31-6. PubMed ID: 15853177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment: treatment of heparin-induced thrombocytopenia.
    Smythe MA; Warkentin TE
    Ann Pharmacother; 2002 Sep; 36(9):1483-4; author reply 1484. PubMed ID: 12196076
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia: a review of current pharmacologic treatment.
    Talati R; Colemen CI; White CM
    Conn Med; 2008 May; 72(5):275-9. PubMed ID: 18593063
    [No Abstract]   [Full Text] [Related]  

  • 10. The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update.
    Prechel M; Walenga JM
    Semin Thromb Hemost; 2008 Feb; 34(1):86-96. PubMed ID: 18393145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-induced thrombocytopenia: diagnosis and management.
    Warkentin TE
    Circulation; 2004 Nov; 110(18):e454-8. PubMed ID: 15520327
    [No Abstract]   [Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management.
    Napolitano LM; Warkentin TE; Almahameed A; Nasraway SA
    Crit Care Med; 2006 Dec; 34(12):2898-911. PubMed ID: 17075368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heparin-induced thrombopenia].
    de Maistre E; Wahl D; Briquel ME; André E; Lecompte T
    Ann Cardiol Angeiol (Paris); 1999 Jan; 48(1):37-41. PubMed ID: 12555357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin induced thrombocytopenia thrombosis (HIT/T) syndrome: diagnosis and treatment.
    Baglin TP
    J Clin Pathol; 2001 Apr; 54(4):272-4. PubMed ID: 11304842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia and cardiovascular patients: recognition and treatment.
    Baker KM; Flattery MP
    Prog Cardiovasc Nurs; 2006; 21(1):47-50. PubMed ID: 16522970
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
    Kiser TH; Jung R; MacLaren R; Fish DN
    Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-induced thrombosis with a normal platelet count.
    Alvarez GF; Bihari D; Collins D
    Crit Care Resusc; 2007 Mar; 9(1):51-3. PubMed ID: 17352667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.
    Rice L; Hursting MJ; Baillie GM; McCollum DA
    J Clin Pharmacol; 2007 Aug; 47(8):1028-34. PubMed ID: 17525167
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin-induced thrombocytopenia and cardiovascular diseases.
    Das P; Ziada K; Steinhubl SR; Moliterno DJ; Hamdalla H; Jozic J; Mukherjee D
    Am Heart J; 2006 Jul; 152(1):19-26. PubMed ID: 16824828
    [No Abstract]   [Full Text] [Related]  

  • 20. Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin.
    Warkentin TE
    Thromb Haemost; 2008 Jan; 99(1):2-3. PubMed ID: 18217128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.